166 related articles for article (PubMed ID: 5650037)
1. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
Hildner FJ; Monto RW; Rebuck JW
Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
[No Abstract] [Full Text] [Related]
2. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
[No Abstract] [Full Text] [Related]
3. [Results obtained in the treatment of post-transfusional hemosiderosis with desferrioxamine ina case of hypoplastic congenital anemia of the Joseph-Blackfan-Diamon type].
Nicolini A; Marca L; Pani C
Minerva Pediatr; 1967 Aug; 19(34):1590-2. PubMed ID: 5610735
[No Abstract] [Full Text] [Related]
4. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
Tillmann W; König R; Schröder K; Schröter W
Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
[No Abstract] [Full Text] [Related]
5. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
Kaung DT
J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
[No Abstract] [Full Text] [Related]
6. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
el-Gholmy A; Khalifa AS; Rahman YA; el-Bagoury I
J Trop Med Hyg; 1969 Jan; 72(1):22-6. PubMed ID: 5773810
[No Abstract] [Full Text] [Related]
7. [The effect of desferrioxamine on the treatment of transfusion hemosiderosis--with special reference to the method of its administration (authors' transl)].
Fujiyama N; Nakazawa K
Rinsho Ketsueki; 1977 Dec; 18(12):1393-400. PubMed ID: 604522
[No Abstract] [Full Text] [Related]
8. Desferrioxamine and transfusional iron overload.
Lancet; 1978 Mar; 1(8062):479-80. PubMed ID: 76025
[No Abstract] [Full Text] [Related]
9. [Long-term study in congenital refractory anemia and secondary siderosis].
Tuschy U; Schmidt U; Meinhold J; Wutke K
Z Gesamte Inn Med; 1982 Apr; 37(7):213-7. PubMed ID: 7102009
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
[No Abstract] [Full Text] [Related]
11. CONGENITAL ERYTHROBLASTIC HYPOPLASIA; TREATMENT OF TRANSFUSION HEMOSIDEROSIS WITH DESFERRIOXAMINE B.
HILDNER FJ; MONTO RW; REBUCK JW
Henry Ford Hosp Med Bull; 1964 Mar; 12():5-13. PubMed ID: 14129631
[No Abstract] [Full Text] [Related]
12. The treatment of Cooley's anemia.
Nathan DG
Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
[No Abstract] [Full Text] [Related]
13. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
14. [Possibilities and limitation of desferrioxamine treatment of transfusion hypersiderosis in children].
Orsini A; Passeron P; Perrimond H; Pierron H
Pediatrie; 1968; 23(5):588-9. PubMed ID: 5675452
[No Abstract] [Full Text] [Related]
15. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
[No Abstract] [Full Text] [Related]
16. Iron chelating therapy in thalassemia: current problems.
Russo G
Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
[No Abstract] [Full Text] [Related]
17. Improved pituitary gonadotrophin response in adult transfusional haemosiderosis following desferrioxamine treatment.
Waters AK
Horm Metab Res; 1982 Jan; 14(1):55. PubMed ID: 7061039
[No Abstract] [Full Text] [Related]
18. Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
Hehlmann R; Schmitz H; Krüger K
Int J Cardiol; 1984 Jun; 5(6):749-53. PubMed ID: 6235195
[TBL] [Abstract][Full Text] [Related]
19. [Subcutaneous administration of deferoxamine in a patient with panmyelopathy and post-transfusion hemosiderosis].
Zdziarska B; Urasiński I
Pol Arch Med Wewn; 1987 Jul; 78(1):48-51. PubMed ID: 3271285
[No Abstract] [Full Text] [Related]
20. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
Sidi Y; Shaklai M; Liban E; Pinkhas J
Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
